Yang Zhao

No ORCID on file · 8 papers in corpus · active 2008-2025

Study types

  • article 5
  • other 3

Condition tags

  • endometriosis 6
  • mesh:D004715 2
article 2025
Journal of biomedical research ·doi:10.7555/jbr.39.20250205

This study investigated differences in reproductive outcomes and vaginal microbiota profiles between two endometrial preparation protocols—letrozole (LE) combined with human menopausal gonadotropin (HMG) and hormone replacement therapy (HRT…

article 2024
Journal of biological engineering ·doi:10.1186/s13036-024-00437-0

BACKGROUND: Endometriosis (EMs) is an enigmatic disease of yet-unknown pathogenesis. Disulfidptosis, a novel identified form of programmed cell death resulting from disulfide stress, stands a chance of treating diverse ailments. However, th…

other 2022
Frontiers in surgery ·doi:10.3389/fsurg.2022.862655

OBJECTIVE: To analyze the risk factors associated with the development of placenta praevia (PP) in first-time pregnant patients and to observe the perinatal clinical outcomes of patients. METHODS: The clinical data of 112 pregnant women wi…

article 2018
·doi:10.1016/j.jacc.2018.08.1055
article 2015
Chinese medical journal ·doi:10.4103/0366-6999.151108

BACKGROUND: We investigated possible biomarkers for endometriosis (EM) using the ClinProt technique and proteomics methods. METHODS: We enrolled 50 patients with EM, 34 with benign ovarian neoplasms and 40 healthy volunteers in this study. …

other 2013
Zhonghua yi xue za zhi

OBJECTIVE: To explore the diagnostic rationales for pelvic retroperitoneal tumors and summarize their therapeutic regimens. METHODS: A total of 16 retroperitoneal tumor patients were recruited. And their general information, previous medic…

article 2008

Objective To study the methods for selecting a magnetic bead in Clinprot system. Methods Serum samples from 10 patients with endometriosis,10 healthy volunteers and 10 patients with other overian diseases were analyzed using either immobili…

other 2008
Zhonghua fu chan ke za zhi

OBJECTIVE: To evaluate the value of human epididymis secretory protein 4 (HE4) and CA(125) in the diagnosis of ovarian malignancy. METHODS: HE4 and CA(125) in the serum specimens of malignant ovarian tumor group (30 cases), benign ovarian …